SCHEMBL2419932

SCHEMBL2419932

Cc1nc(-c2ccccc2)oc1CCl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.46
KDM4E B2RXH2 3/20 0.44
PPARD Q03181 2/20 0.43
FFAR1 O14842 1/20 0.43
SMN1; SMN2 Q16637 6/20 0.42
HPGD P15428 6/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
POLB P06746 2/20 0.42
CASP3 P42574 2/20 0.42
SENP7 Q9BQF6 2/20 0.42
SENP6 Q9GZR1 2/20 0.42
SENP8 Q96LD8 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
VDR P11473 2/20 0.41
HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8989102 0.86 IKBKB (0.45) ALDH1A1LMNAKDM4ESMN1; SMN2HPGD
SCHEMBL9830911 0.84 KDM4E (0.50) ALDH1A1LMNAGAAKDM4ESMN1; SMN2
SCHEMBL14382241 0.84 GAA (0.47) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL6377222 0.82 KDM4E (0.51) GAAKDM4EPPARDFFAR1SMN1; SMN2
SCHEMBL6376282 0.82 GAA (0.46) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL5013674 0.82 NOTUM (0.47) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL14382242 0.81 KDM4E (0.47) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL4553353 0.81 GAA (0.45) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL4435376 0.79 GAA (0.44) ALDH1A1GAAKDM4EPPARDFFAR1
SCHEMBL820892 0.79 GAA (0.48) ALDH1A1GAAKDM4EPPARDFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 US disclosed
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof MITSUBISHI PHAMA CORPORATION (JP) 2008-07-10 US disclosed
EP-1816128-A1 CARBOXYLIC ACID DERIVATIVE CONTAINING THIAZOLE RING AND PHARMACEUTICAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2007-08-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167307-A1 Carboxylic Acid Derivative Containing Thiazole Ring and Pharmaceutical Use Thereof PPARA, PPARD, PPARG ALDH1A1 175/4885LMNA 3376/4885GAA 684/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.